股腘动脉旁路术后肝素涂层ePTFE人工血管感染的发生率与危险因素
该多中心注册研究回顾性分析了2002至2016年间1400例采用肝素涂层ePTFE人工血管行腹股沟下股腘动脉旁路术的病例,人工血管感染(PVGI)发生率为2.3%,中位发生时间5个月,1年免于PVGI为98%、5年为97%。
要点
- 股腘动脉旁路术后肝素涂层ePTFE人工血管感染率低(2.3%),但后果严重。
- PVGI患者1年免于大截肢显著低于无PVGI者(67.0% vs 88.5%)。
核心结论
- 真实世界多中心数据显示股腘动脉旁路术后肝素涂层ePTFE人工血管感染率为2.3%,但伴随显著死亡和肢体丧失风险。
- 严重肢体缺血是PVGI的唯一显著预测因素,但缺血性溃疡或坏疽未显示预测作用,需更全面数据证实。
研究设计与样本
- 基于多中心注册的回顾性研究,纳入2002至2016年间1400例使用肝素涂层ePTFE人工血管的腹股沟下血运重建手术。
- PVGI定义为人工血管直接受累且移植物或血管周围材料细菌培养阳性、术中发现明显脓液或移植物未整合、或感染伤口中移植物暴露。
主要发现
- 严重肢体缺血是旁路手术的主要指征(n=915,65%)。
- 中位随访29个月(范围1-168个月,IQR 12-60个月),共33例(2.3%)肝素涂层ePTFE人工血管感染,中位发生时间5个月(范围1-54个月,IQR 2.00-13.25个月)。
- 1年免于PVGI为98%(标准误0.4,95%CI 97.2-98.9),5年为97%(标准误0.6,95%CI 95.6-98.0)。
临床怎么用
- 对于接受股腘动脉旁路术的严重肢体缺血患者,应警惕PVGI风险,术后需监测感染征象。
- PVGI发生后截肢风险显著增加,治疗决策需权衡保肢与感染控制。
局限性
- 回顾性注册研究设计可能存在选择偏倚和信息偏倚。
- 缺血性溃疡或坏疽未显示预测PVGI,作者认为需更全面数据证实结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To analyze the prevalence and predictors of prosthetic vascular graft infection (PVGI) in a multicenter registry. METHODS: This registry-based, multicenter study retrospectively evaluated PVGI that developed after infrainguinal revascularization performed with a heparin-bonded expanded polytetrafluoroethylene graft that was used in 1400 interventions between 2002 and 2016. A prosthetic graft with infection was defined as direct involvement of the graft with positive bacterial cultures of graft or perigraft material, intraoperative gross purulence or failure of graft incorporation, or exposed graft in an infected wound. RESULTS: Critical limb ischemia (CLI) was the main indication for bypass (n = 915 [65%]). The median duration of follow-up was 29 months (range, 1-168 months; interquartile range, 12-60 months). A total of 33 heparin-bonded expanded polytetrafluoroethylene grafts (2.3%) became infected; the median time to occurrence was 5 months (range, 1-54 months; interquartile range; 2.00-13.25 months). Freedom from PVGI at 1 year was 98% (standard error, 0.4; 95% confidence interval [CI], 97.2-98.9), and 97% (standard error, 0.6; 95% CI, 95.6-98.0) at 5 years. The multivariate model identified CLI (P = .042; hazard ratio, 0.39; 95% CI, 0.164-0.969) to be independently associated with PVGI. In-hospital mortality of PVGI treatment was 12% (n = 4/33). Freedom from major amputation was significantly different between patients with PVGI and those who did not experience this complication (at 1 year, 67.0% vs 88.5%; Log-rank χ2 = 22.5; P = .001). CONCLUSIONS: In our "real-world" multicenter experience the prevalence of PVGI after infrainguinal femoropopliteal bypasses was relatively low at 2.3%, but still associated with significant mortality and limb loss. CLI was the only significant predictor of PVGI. This conclusion is reasonable; however, more comprehensive data are required to confirm these findings, because the presence of ischemic ulcers or gangrene was not predictive of PVGI.
引用
- Piffaretti G, Dorigo W, Ottavi P, et al. Prevalence and risk factors for heparin-bonded expanded polytetrafluoroethylene vascular graft infection after infrainguinal femoropopliteal bypasses. J Vasc Surg. 2019. PMID: 31147126. doi:10.1016/j.jvs.2019.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。